# Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

> **NCT04368546** · — · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 6 (actual)

## Conditions studied

- Renal Cell Cancer Metastatic
- Hypertension
- Sodium Imbalance

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT04368546
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368546, "Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04368546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*